Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ACHV

Achieve Life Sciences Inc

Sep 15 • 04:00PM ET

3.04

-0.04 -1.30 %

Healthcare • Biotechnology • Canada • NASD

Peers: ARWR GERN IMMP SGMO ANIP AMRN ALDX ATRA AXSM CRBP

| Held by: VTI SURI VXF IWC MSSM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.46	Insider Own	16.67%	Shs Outstand	49.69M	Perf Week	3.75%
Market Cap	155.34M	Forward P/E	-	EPS next Y	-1.06	Insider Trans	-2.10%	Shs Float	42.59M	Perf Month	19.22%
Enterprise Value	109.90M	PEG	-	EPS next Q	-0.24	Inst Own	53.97%	Short Float	12.17%	Perf Quarter	-6.46%
Income	-50.42M	P/S	-	EPS this Y	4.84%	Inst Trans	94.48%	Short Ratio	3.88	Perf Half Y	10.14%
Sales	0.00M	P/B	3.62	EPS next Y	9.83%	ROA	-81.50%	Short Interest	5.18M	Perf YTD	-13.64%
Book/sh	0.84	P/C	2.80	EPS next 5Y	-	ROE	-120.11%	52W High	5.31 -42.75%	Perf Year	-28.97%
Cash/sh	1.08	P/FCF	-	EPS past 3/5Y	32.75% 50.01%	ROIC	-100.11%	52W Low	1.84 65.22%	Perf 3Y	-32.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.44% 8.44%	Perf 5Y	-59.74%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-32.50%	Oper. Margin	-	ATR (14)	0.22	Perf 10Y	-99.95%
Dividend Ex-Date	-	Quick Ratio	6.64	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	54.55	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.64	EPS Q/Q	-48.76%	SMA20	2.74%	Beta	1.58	Target Price	15.50
Payout	-	Debt/Eq	0.24	Sales Q/Q	-	SMA50	11.73%	Rel Volume	0.62	Prev Close	3.08
Employees	25	LT Debt/Eq	0.21	Earnings	Aug 07 BMO	SMA200	-0.27%	Avg Volume	1.34M	Price	3.04
IPO	Oct 12, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-1.09% -	Trades		Volume	824,936	Change	-1.30%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-21-25	Initiated	H.C. Wainwright	Buy	$12
Nov-14-24	Initiated	Rodman & Renshaw	Buy	$12
Sep-27-24	Initiated	Raymond James	Strong Buy	$20
May-10-23	Reiterated	Maxim Group	Buy	$8 → $20
Jun-23-21	Initiated	Oppenheimer	Outperform	$23

Sep-11-25 05:01PM	Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer (GlobeNewswire)
Sep-03-25 08:30AM	Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
Sep-02-25 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Aug-25-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +13.36%
Aug-21-25 02:11PM	Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years (Benzinga) +12.02%
07:30AM	Loading…
Aug-07-25 07:30AM	Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program (GlobeNewswire)
Jul-29-25 08:30AM	Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference (GlobeNewswire) -5.20%
Jul-24-25 08:30AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025 (GlobeNewswire)
Jul-13-25 06:15AM	Raymond James Predicts Up to ~760% Surge for These 2 Strong Buy Stocks (TipRanks)
Jul-07-25 08:56AM	Should You Hold Achieve Life Sciences (ACHV)? (Insider Monkey) -5.05%
Jul-06-25 04:00AM	Omnicom, Achieve Life Sciences Partner for AI-Driven Launch of New Nicotine Dependence Treatment (Insider Monkey)
Jun-30-25 07:52PM	Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Securities (GlobeNewswire)
Jun-26-25 11:43PM	Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering (GlobeNewswire) -7.63% -36.47%
04:03PM	Achieve Life Sciences Announces Proposed Underwritten Public Offering (GlobeNewswire)
04:02PM	Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades (GlobeNewswire)
04:01PM	Loading…
04:01PM	Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation (GlobeNewswire)
May-28-25 08:30AM	Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-25 08:30AM	Achieve Life Sciences to Present New Data at the 2025 ATS International Conference Demonstrating that Cytisinicline Reduced Cravings and Nicotine Intake (GlobeNewswire)
May-14-25 03:06AM	Achieve Life Sciences Inc (ACHV) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -6.42%
01:56AM	Q1 2025 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:30AM	Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program (GlobeNewswire) +6.85%
May-06-25 08:30AM	Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025 (GlobeNewswire) -6.25%
Apr-22-25 11:26AM	Achieve Life Sciences announces publication of results from Phase 3 ORCA-3 trial (TipRanks) +10.22%
Apr-21-25 11:19AM	Achieve Life Sciences Announces Cytisinicline Phase 3 ORCA-3 Trial Publication on Smoking Cessation in JAMA Internal Medicine (GlobeNewswire) +13.07%
Mar-20-25 06:25PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (InsiderMonkey)
Mar-12-25 03:14AM	Q4 2024 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents) -9.25%
03:02AM	Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
Mar-11-25 07:30AM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program (GlobeNewswire)
Mar-07-25 08:30AM	Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference (GlobeNewswire)
Mar-06-25 08:30AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 (GlobeNewswire) +9.03%
07:29AM	Loading…
Feb-18-25 07:29AM	Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) (Insider Monkey)
Feb-11-25 08:30AM	Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference (GlobeNewswire)
Feb-10-25 08:30AM	Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial (GlobeNewswire) +15.74%
Jan-24-25 12:14PM	Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory (Insider Monkey)
Jan-10-25 08:30AM	Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors (GlobeNewswire)
Jan-07-25 08:30AM	Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission (GlobeNewswire) +5.07%
Jan-06-25 08:30AM	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week (GlobeNewswire)
Jan-02-25 11:04AM	Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1? (Insider Monkey)
Dec-09-24 08:30AM	Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer (GlobeNewswire)
Dec-03-24 08:30AM	Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA (GlobeNewswire)
Nov-14-24 08:30AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-08-24 02:01PM	Achieve Life Sciences Inc (ACHV) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) -7.40%
Nov-07-24 04:05PM	Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Oct-24-24 08:00AM	Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024 (GlobeNewswire)
Oct-23-24 08:00AM	Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting (GlobeNewswire)
Oct-16-24 08:00AM	Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline (GlobeNewswire)
Oct-10-24 08:00AM	Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting (GlobeNewswire)
Oct-01-24 08:45AM	Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs (GlobeNewswire)
Aug-26-24 04:30PM	Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors (GlobeNewswire)
Aug-13-24 04:01PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update (GlobeNewswire)
Jul-31-24 08:00AM	Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence (GlobeNewswire)
Jul-29-24 08:00AM	Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank (GlobeNewswire)
Jul-25-24 08:00AM	Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 (GlobeNewswire)
Jul-15-24 08:00AM	Milestone Pharmaceuticals Refreshes Board of Directors (GlobeNewswire)
Jul-09-24 08:00AM	Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 (GlobeNewswire)
Jul-01-24 08:00AM	Achieve Life Sciences Announces Addition to the U.S. Russell 3000 and Russell Microcap Indexes (GlobeNewswire)
May-29-24 08:00AM	Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes (GlobeNewswire)
May-17-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting (GlobeNewswire)
May-13-24 08:55AM	Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating (MT Newswires)
May-10-24 03:47PM	Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results (GuruFocus.com)
12:41PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 04:01PM	Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update (GlobeNewswire)
May-06-24 11:16AM	Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine (GlobeNewswire)
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-25-24 08:00AM	Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 (GlobeNewswire)
Apr-11-24 08:00AM	Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference (GlobeNewswire)
Apr-01-24 03:30PM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 06:24AM	Q4 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 08:53PM	ACHV Stock Earnings: Achieve Life Sciences Beats EPS for Q4 2023 (InvestorPlace)
05:32PM	Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval (GuruFocus.com)
04:01PM	Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update (GlobeNewswire)
Mar-20-24 08:00AM	Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting (GlobeNewswire)
Mar-14-24 08:00AM	Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024 (GlobeNewswire)
Mar-08-24 08:35AM	Life Science Virtual Investor Forum Presentations Now Available for Online Viewing (GlobeNewswire)
Mar-06-24 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Mar-05-24 08:35AM	Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024 (GlobeNewswire)
Feb-29-24 08:01AM	Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission (GlobeNewswire) -9.19%
08:00AM	Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire)
Dec-15-23 08:35AM	Life Science Investor Forum: Presentations Now Available for Online Viewing (GlobeNewswire)
Dec-13-23 08:00AM	TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors (GlobeNewswire) +5.40%
Dec-12-23 01:02PM	Life Science Investor Forum Agenda Announced for December 14th, 2023 (GlobeNewswire) -42.20%
09:10AM	Why Is Achieve Life Sciences (ACHV) Stock Down 25% Today? (InvestorPlace)
Dec-11-23 04:30PM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Nov-11-23 10:36AM	Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 10:01AM	Q3 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-09-23 04:00PM	Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate Update (GlobeNewswire)
Oct-26-23 08:00AM	Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023 (GlobeNewswire)
Oct-03-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire)
Sep-11-23 08:00AM	Achieve Life Sciences Announces Presentation of Cytisinicline E-Cigarette Cessation (ORCA-V1) Results at Society for Research on Nicotine and Tobacco Europe (SRNT-E) Annual Meeting (GlobeNewswire)
Sep-07-23 08:00AM	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences (GlobeNewswire) -5.24%
Aug-16-23 10:30AM	ACHV: 2Q:23 Results (Zacks)
Aug-15-23 10:25PM	Q2 2023 Achieve Life Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 04:00PM	Achieve Life Sciences Reports Financial Results for Second Quarter 2023 and Provides Corporate Update (GlobeNewswire)
Aug-01-23 08:00AM	Achieve Life Sciences to Announce Second Quarter 2023 Financial Results and Host Conference Call and Webcast (GlobeNewswire)
Jul-18-23 08:00AM	Achieve Life Sciences Announces Presentation at 2023 American Society of Pharmacognosy Annual Meeting (GlobeNewswire)
Jul-11-23 11:23AM	Achieve Life Sciences Announces Publication of Cytisinicline Phase 3 ORCA-2 Smoking Cessation Trial in Journal of the American Medical Association (JAMA) (GlobeNewswire)
May-25-23 09:00AM	Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering (GlobeNewswire) -6.07%
07:16AM	ACHV: ORCA-3 Topline (Zacks Small Cap Research)
May-24-23 06:10AM	Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) Shift From Loss To Profit (Simply Wall St.)
May-23-23 02:46PM	Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial (Benzinga) -23.80%

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wan Jerry	Principal Accounting Officer	Sep 04 '25	Option Exercise	0.00	34,100	0	46,764	Sep 08 04:59 PM
Wan Jerry	Principal Accounting Officer	Sep 04 '25	Sale	2.77	14,070	38,974	32,694	Sep 08 04:59 PM
KING THOMAS BRAXTON	Director	Sep 04 '25	Option Exercise	0.00	455,000	0	455,000	Sep 08 04:54 PM
KING THOMAS BRAXTON	Director	Sep 04 '25	Sale	2.77	139,858	387,407	315,142	Sep 08 04:54 PM
JACOBS CINDY	President & CMO	Sep 04 '25	Option Exercise	0.00	110,000	0	143,214	Sep 08 04:51 PM
JACOBS CINDY	President & CMO	Sep 04 '25	Sale	2.77	27,629	76,532	115,585	Sep 08 04:51 PM
Xinos Jaime	Chief Commercial Officer	Sep 04 '25	Option Exercise	0.00	69,000	0	95,286	Sep 08 04:39 PM
Xinos Jaime	Chief Commercial Officer	Sep 04 '25	Sale	2.77	20,854	57,766	74,432	Sep 08 04:39 PM
Oki Mark K	Chief Financial Officer	Mar 17 '25	Buy	2.89	10,000	28,887	10,000	Mar 19 04:38 PM
Stewart Richard Alistair	Chieve Executive Officer	Mar 17 '25	Buy	2.86	10,000	28,598	60,876	Mar 19 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACHV

Achieve Life Sciences Inc

Upgrade your FINVIZ experience